| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | 3.209 | 11.280 | 13.289 | 7.619 |
| Total Income - EUR | - | - | - | - | - | - | 3.209 | 11.281 | 13.289 | 8.365 |
| Total Expenses - EUR | - | - | - | - | - | - | 2.770 | 10.604 | 11.911 | 11.360 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | 439 | 677 | 1.378 | -2.996 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | 343 | 389 | 1.004 | -2.996 |
| Employees | - | - | - | - | - | - | 0 | 0 | 0 | 1 |
Check the financial reports for the company - Biobys Bogdan S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | 0 | 0 | 1.803 | 1.196 |
| Current Assets | - | - | - | - | - | - | 979 | 815 | 2.262 | 510 |
| Inventories | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | - | - | 61 | 0 | 303 | 101 |
| Cash | - | - | - | - | - | - | 918 | 815 | 1.958 | 410 |
| Shareholders Funds | - | - | - | - | - | - | 383 | 773 | 1.775 | -1.231 |
| Social Capital | - | - | - | - | - | - | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | - | 596 | 42 | 487 | 1.741 |
| Income in Advance | - | - | - | - | - | - | 0 | 0 | 1.803 | 1.196 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4941 - 4941" | |||||||||
| CAEN Financial Year |
4941
|
|||||||||
Comments - Biobys Bogdan S.r.l.